Literature DB >> 22006731

Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain.

Marlon S Mathews1, David Chighvinadze, H Michael Gach, Francisco A Uzal, Steen J Madsen, Henry Hirschberg.   

Abstract

BACKGROUND AND
OBJECTIVE: Failure of treatment for high-grade gliomas is usually due to local recurrence at the site of surgical resection indicating that a more aggressive form of local therapy such as photodynamic therapy (PDT) could be of benefit. The increase in brain edema following PDT using endogenous and exogenous photosensitizers was compared in terms of animal survival, MR imaging, and histopathological changes in normal brain.
MATERIALS AND METHODS: Fischer rats were exposed to increasing laser light treatment following intraperitoneal injection of either the photosensitizers 5-aminolevulinic acid (ALA) or aluminum phthalocyanine disulfonate (AlPcS2a). Light treatment was applied either via an optical fiber inserted directly into the brain parenchyma or through a fiber applied to the surface of the intact skull. Edema development was followed by T2-weighted MR imaging.
RESULTS: ALA and AlPcS2a PDT resulted in a fluence dependent increase in cerebral edema and mortality. AlPcS2a PDT showed significant edema and mortality even at low fluences following interstitial light delivery, which was reduced with surface illumination. The mechanism of edema was determined to be vasogenic by response to steroid therapy and confirmed on histological images.
CONCLUSIONS: T2 and contrast enhanced T1 MRI scanning proved to be a highly effective and noninvasive modality in following the development of the edema reaction and the degree and time course of blood-brain barrier dysfunction thus allowing the use of fewer animals. ALA mediated PDT induced a lower edema reaction than that observed with the photosensitizer AlPcS2a.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006731      PMCID: PMC4124831          DOI: 10.1002/lsm.21135

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  36 in total

1.  The relation between intracrainal pressure, mean arterial pressure and cerebral blood flow in patients with severe head injury.

Authors:  W Gobiet; W Grote; W J Bock
Journal:  Acta Neurochir (Wien)       Date:  1975       Impact factor: 2.216

Review 2.  Photochemical internalisation in drug and gene delivery.

Authors:  Anders Høgset; Lina Prasmickaite; Pål K Selbo; Marit Hellum; Birgit Ø Engesaeter; Anette Bonsted; Kristian Berg
Journal:  Adv Drug Deliv Rev       Date:  2004-01-13       Impact factor: 15.470

3.  Cerebral blood flow in patients with intracranial pressure elevation due to traumatic brain edema.

Authors:  W A Tweed; J Overgaard
Journal:  Can J Neurol Sci       Date:  1976-02       Impact factor: 2.104

4.  Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.

Authors:  Q Peng; T Warloe; J Moan; A Godal; F Apricena; K E Giercksky; J M Nesland
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

5.  Use of betamethasone in reduction of cerebral edema.

Authors:  J A Johnson; S Assam
Journal:  Mil Med       Date:  1966-01       Impact factor: 1.437

6.  Experiences with dexamethasone treatment of intracranial pressure caused by brain tumours.

Authors:  A Gårde
Journal:  Acta Neurol Scand Suppl       Date:  1965

7.  Experimental research photodynamic effects in perifocal, oedematous brain tissue.

Authors:  C Goetz; A Hasan; W Stummer; A Heimann; O Kempski
Journal:  Acta Neurochir (Wien)       Date:  2002-02       Impact factor: 2.216

8.  Photodynamic therapy: a means to enhanced drug delivery to tumors.

Authors:  John W Snyder; William R Greco; David A Bellnier; Lurine Vaughan; Barbara W Henderson
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

Review 9.  The blood-brain barrier: an overview: structure, regulation, and clinical implications.

Authors:  Praveen Ballabh; Alex Braun; Maiken Nedergaard
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

10.  Pathophysiological aspects of brain edema.

Authors:  I Klatzo
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

View more
  7 in total

1.  Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption.

Authors:  Steen J Madsen; H Michael Gach; Seok Jin Hong; Francisco A Uzal; Qian Peng; Henry Hirschberg
Journal:  Lasers Surg Med       Date:  2013-08-30       Impact factor: 4.025

Review 2.  Cell Mediated Photothermal Therapy of Brain Tumors.

Authors:  Henry Hirschberg; Steen J Madsen
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-11       Impact factor: 4.147

3.  Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.

Authors:  Maximilien Vermandel; Clément Dupont; Fabienne Lecomte; Henri-Arthur Leroy; Constantin Tuleasca; Serge Mordon; Constantinos G Hadjipanayis; Nicolas Reyns
Journal:  J Neurooncol       Date:  2021-03-20       Impact factor: 4.130

4.  ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia.

Authors:  Carl J Fisher; Carolyn Niu; Warren Foltz; Yonghong Chen; Elena Sidorova-Darmos; James H Eubanks; Lothar Lilge
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

5.  Efficacy of ruthenium coordination complex-based Rutherrin in a preclinical rat glioblastoma model.

Authors:  Manjunatha Akathatti Munegowda; Carl Fisher; Daniel Molehuis; Warren Foltz; Mark Roufaiel; Jay Bassan; Mark Nitz; Arkady Mandel; Lothar Lilge
Journal:  Neurooncol Adv       Date:  2019-05-28

Review 6.  Like a bolt from the blue: phthalocyanines in biomedical optics.

Authors:  Nawal Sekkat; Hubert van den Bergh; Tebello Nyokong; Norbert Lange
Journal:  Molecules       Date:  2011-12-23       Impact factor: 4.411

7.  Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging.

Authors:  Henriette S de Bruijn; Vida Mashayekhi; Tom J L Schreurs; Pieter B A A van Driel; Gustav J Strijkers; Paul J van Diest; Clemens W G M Lowik; Ann L B Seynhaeve; Timo L M Ten Hagen; Jeanine J Prompers; Paul M P van Bergen En Henegouwen; Dominic J Robinson; Sabrina Oliveira
Journal:  Theranostics       Date:  2020-01-20       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.